Published in Dig Dis on January 01, 2004
Severe acute pancreatitis: Clinical course and management. World J Gastroenterol (2007) 1.55
Interleukin-18, together with interleukin-12, induces severe acute pancreatitis in obese but not in nonobese leptin-deficient mice. Proc Natl Acad Sci U S A (2008) 1.13
Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study. Ann Surg (2007) 1.09
Evaluation of diagnostic findings and scoring systems in outcome prediction in acute pancreatitis. World J Gastroenterol (2007) 1.01
Hemophagocytic Lymphohistiocytosis Complicating T-Cell Lymphoma in a Patient with HIV Infection. Case Rep Hematol (2013) 0.91
Clinical and pathologic characteristics of pancreatic necrosis in critically ill children. World J Emerg Med (2011) 0.78
Ischemia-reperfusion rat model of acute pancreatitis: protein carbonyl as a putative early biomarker of pancreatic injury. Clin Exp Med (2014) 0.77
Surgery in Pancreatic Necrosis-Challenges and Outcomes in an Industrial Hospital. Indian J Surg (2015) 0.75
Scoring of human acute pancreatitis: state of the art. Langenbecks Arch Surg (2013) 0.75
Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology (1986) 3.95
Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet (2000) 3.16
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg (2001) 2.94
Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology (1993) 2.86
Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group. Gastroenterology (1993) 2.83
Octreotide prophylaxis is not beneficial for biochemical activity and clinical severity of postoperative pancreatic fistula after pancreatic surgery. Dig Surg (2013) 2.72
Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene (1997) 2.58
Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. J Clin Invest (1992) 2.54
Duodenum-preserving resection of the head of the pancreas in patients with severe chronic pancreatitis. Surgery (1985) 2.41
Bacterial infection and extent of necrosis are determinants of organ failure in patients with acute necrotizing pancreatitis. Br J Surg (1999) 2.38
Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg (1995) 2.36
Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. Anticancer Res (1993) 2.15
Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res (1993) 2.08
Overexpression of HER2/neu oncogene in human pancreatic carcinoma. Hum Pathol (1993) 2.05
Analysis of nerves in chronic pancreatitis. Gastroenterology (1988) 2.01
Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer (1999) 1.99
Carcinoid of the ampulla of Vater. Clinical characteristics and morphologic features. Cancer (1994) 1.97
Management of sterile necrosis in instances of severe acute pancreatitis. J Am Coll Surg (1995) 1.94
High coincidence of Mirizzi syndrome and gallbladder carcinoma. Surgery (1997) 1.89
Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res (1995) 1.89
Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut (2000) 1.86
Clinical relevance of caspase-1 activated cytokines in acute pancreatitis: high correlation of serum interleukin-18 with pancreatic necrosis and systemic complications. Crit Care Med (2001) 1.79
Results of surgical treatment of necrotizing pancreatitis. World J Surg (1985) 1.61
Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells. Oncogene (1999) 1.60
Prognostic value of CA 19-9 serum course in pancreatic cancer. Hepatogastroenterology (1998) 1.58
The suprapubic approach for laparoscopic appendectomy. Surg Endosc (2001) 1.56
Cystic tumours of the pancreas: diagnostic accuracy, pathologic observations and surgical consequences. Langenbecks Arch Surg (1998) 1.55
The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut (1997) 1.54
Randomized trial of duodenum-preserving pancreatic head resection versus pylorus-preserving Whipple in chronic pancreatitis. Am J Surg (1995) 1.52
[Laparoscopic cholecystectomy versus mini-lap-cholecystectomy. Results of a prospective, randomized study]. Chirurg (1992) 1.52
Randomized clinical trial of efficacy and costs of three dissection devices in liver resection. Br J Surg (2009) 1.50
Immune cell infiltration and growth-associated protein 43 expression correlate with pain in chronic pancreatitis. Gastroenterology (1997) 1.49
Genetic alterations in chronic pancreatitis: evidence for early occurrence of p53 but not K-ras mutations. Br J Surg (1998) 1.46
Early severe acute pancreatitis: characteristics of a new subgroup. Pancreas (2001) 1.42
Oxygen free radicals in acute pancreatitis of the rat. Gut (1990) 1.42
[Benign tumors of the Vater's papilla]. Dtsch Med Wochenschr (2000) 1.41
Surgical treatment of necrotizing pancreatitis by necrosectomy and closed lavage: changing patient characteristics and outcome in a 19-year, single-center series. Surgery (2005) 1.41
Regional chemotherapy in liver metastases of colorectal carcinoma: monitoring with arterial computed tomography. Cancer Invest (1990) 1.40
Importance of the duodenal passage and pouch volume after total gastrectomy and reconstruction with the Ulm pouch: prospective randomized clinical study. World J Surg (1996) 1.40
[Stenting in chronic pancreatitis--the mistakes and limitations]. Z Gastroenterol (2000) 1.38
Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. Cancer Res (1997) 1.33
Identification of pancreas necrosis in severe acute pancreatitis: imaging procedures versus clinical staging. Gut (1986) 1.32
A surgical and pathological based classification of resective treatment of pancreatic cancer. Summary of an international workshop on surgical procedures in pancreatic cancer. Dig Surg (1999) 1.32
Improved methods to measure end products of nitric oxide in biological fluids: nitrite, nitrate, and S-nitrosothiols. Nitric Oxide (1997) 1.31
Human pancreatic tissue concentration of bactericidal antibiotics. Gastroenterology (1992) 1.31
Pathophysiologic role of oxygen free radicals in acute pancreatitis: initiating event or mediator of tissue damage? Ann Surg (2000) 1.26
A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut (1999) 1.26
Progress in acute pancreatitis. Surg Gynecol Obstet (1988) 1.25
Balance of expression of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in chronic pancreatitis. Z Gastroenterol (1994) 1.25
Surgical treatment of infected necrosis. World J Surg (1997) 1.25
[Antibiotic use in necrotizing pancreatitis. Results of a controlled study]. Dtsch Med Wochenschr (1997) 1.24
Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer. Cancer Res (1998) 1.24
Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography. Gut (1995) 1.23
FDG PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies. J Nucl Med (1998) 1.22
Is (18)F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making? Am J Surg (2000) 1.20
Reperfusion injury after intestinal ischemia. Crit Care Med (1993) 1.20
Role of phospholipase A2 in human acute pancreatitis. Gastroenterology (1989) 1.20
Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma. J Nucl Med (1997) 1.19
Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness. Cancer Res (1996) 1.19
Intraductal papillary mucinous tumor of the pancreas. Am J Surg (1999) 1.18
Morphogenesis and possible precursor lesions of invasive carcinoma of the papilla of Vater: epithelial dysplasia and adenoma. Hum Pathol (1985) 1.18
Leukocytes, the Janus cells in inflammatory disease. Langenbecks Arch Surg (1999) 1.18
Total gastrectomy. Updated operative mortality and long-term survival with particular reference to patients older than 70 years of age. Ann Surg (1996) 1.15
Endoscopic mucosal resection for advanced non-polypoid colorectal adenoma and early stage carcinoma. Surg Endosc (2002) 1.15
PMN-elastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas (1991) 1.14
Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells. Cancer (2000) 1.14
[Experiences with duodenum-sparing pancreas head resection in chronic pancreatitis]. Chirurg (1980) 1.13
Role of ultrasonographically guided fine-needle aspiration cytology in the diagnosis of infected pancreatic necrosis. Br J Surg (1998) 1.12
Increased expression of insulin receptor substrate-1 in human pancreatic cancer. Biochem Biophys Res Commun (1996) 1.12
Synthesis and expression of transforming growth factor beta-1, beta-2, and beta-3 in the endocrine and exocrine pancreas. Diabetes (1993) 1.12
Changes in peptidergic innervation in chronic pancreatitis. Pancreas (1992) 1.12
Oxidative stress in acute and chronic pancreatitis. Am J Clin Nutr (1995) 1.11
Natural history of acute pancreatitis and the role of infection. Baillieres Best Pract Res Clin Gastroenterol (1999) 1.11
Oxygen radicals in experimental acute pancreatitis. Hepatogastroenterology (1994) 1.10
Duodenum-preserving pancreatic head resection: Long-term results. J Gastrointest Surg (2006) 1.10
Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses. Pancreas (2000) 1.10
p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis. Cancer Lett (1993) 1.09
Detection of liver metastases from pancreatic cancer using FDG PET. J Nucl Med (1999) 1.08
Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions. Oncogene (1997) 1.08
Total mesorectal excision preserves male genital function compared with conventional rectal cancer surgery. Br J Surg (2001) 1.08
[Indications for laparoscopic pancreas operations: results of a consensus conference and the previous laparoscopic pancreas register]. Chirurg (2012) 1.07
Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes. Cancer Res (1999) 1.07
Increased expression of acidic and basic fibroblast growth factors in chronic pancreatitis. Am J Pathol (1994) 1.07
Diagnostic value of CA 19-9 in patients with pancreatic cancer and nonspecific gastrointestinal symptoms. J Gastrointest Surg (2006) 1.07
Hemodynamic data pattern in patients with acute pancreatitis. Gastroenterology (1986) 1.06
Gastric emptying following pylorus-preserving Whipple and duodenum-preserving pancreatic head resection in patients with chronic pancreatitis. Am J Surg (1997) 1.05
Interaction of pancreatic ductal carcinoma with nerves leads to nerve damage. Gastroenterology (1994) 1.04
Endotoxemia and acute-phase proteins in major abdominal surgery. Am J Surg (2001) 1.04
Palliative and adjuvant regional chemotherapy in pancreatic cancer. Eur J Surg Oncol (1997) 1.03
Reduced membranous and ectopic cytoplasmic expression of beta -catenin correlate with cyclin D1 overexpression and poor prognosis in pancreatic cancer. Int J Cancer (2001) 1.02
Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis. Br J Surg (2002) 1.02
Is follow-up of colorectal cancer patients worthwhile? Dis Colon Rectum (1993) 1.02
The role of polymorphonuclear leukocytes and oxygen-derived free radicals in experimental acute pancreatitis: mediators of local destruction and activators of inflammation. FEBS Lett (1999) 1.02
[Effect of tumor size and lymph node status on the prognosis of pancreatic cancer]. Chirurg (1989) 1.01
Differential effects of caspase-1/interleukin-1beta-converting enzyme on acinar cell necrosis and apoptosis in severe acute experimental pancreatitis. Lab Invest (2001) 1.00
Increased cyclin D1 in human pancreatic cancer is associated with decreased postoperative survival. Oncology (1998) 1.00
A metastatic endocrine-neurogenic tumor of the ampulla of Vater with multiple endocrine immunoreaction--malignant paraganglioma? Digestion (1985) 1.00
Intraoperative assessment of intestinal viability by laser Doppler flowmetry for surgery of ruptured abdominal aortic aneurysms. World J Surg (1998) 0.99
Diagnosis and staging of pancreatic cancer by positron emission tomography. World J Surg (1999) 0.99